CHAT and Alzheimer disease: Keeping in mind this urging need for novel biomarkers for early diagnosis of AD, the present work aimed at the discovery of novel ChAT ligands with the potential of radio-labeling, which can be used as an in vivo PET tracer to map regional brain distribution of ChAT, and thereby study the health of cholinergic network in CNS and neurodegeneration for diagnostic purposes.